文献速递血栓与止血

肝病患者再平衡止血概念:ISTH SSC工作组通讯

The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease.
PubMed 文献 · J Thromb Haemost · 2021-01-01

肝病患者止血系统发生复杂改变,常规检测提示低凝但也可发生血栓。ISTH SSC工作组于2020年成立,旨在传播肝病出血与血栓防治新概念,本文阐述止血变化、常规检测局限及再平衡止血概念。

要点

  • 肝病患者常规止血检测异常但促凝与抗凝通路改变相称,呈再平衡止血。
  • 再平衡止血较正常肝功能者更脆弱,患者可发生出血或血栓事件。
  • 常规止血检测不能准确反映肝病患者的止血状态。

核心结论

  • 肝病患者止血系统促凝与抗凝通路改变相称,形成再平衡止血但更脆弱,可发生出血或血栓事件。

研究设计与样本

  • ISTH SSC肝病止血管理工作组通讯文件,阐述肝病止血变化、常规检测局限及再平衡止血概念。

主要发现

  • 晚期肝病常见血小板减少、凝血酶原时间和活化部分凝血活酶时间延长及血浆纤维蛋白原降低。
  • 常规止血检测提示低凝状态,但肝病患者也易发生血栓事件。
  • 肝病患者促凝与抗凝通路改变相称,形成新的止血平衡但较正常肝功能者更脆弱。

临床怎么用

  • 临床管理需基于再平衡止血概念修订,不应仅凭常规止血检测判断出血或血栓风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with liver diseases acquire complex alterations in their hemostatic system that may lead to abnormalities in routine diagnostic test of hemostasis. Thrombocytopenia, prolongations in the prothrombin time and activated partial thromboplastin time, and decreased plasma fibrinogen are common in patients with advanced liver disease. Historically, liver diseases therefore have been classified as an acquired bleeding disorder. Laboratory and clinical observations have demonstrated that although routine diagnostic tests of hemostasis suggest a hypocoagulable state, patients with liver disease also tend to develop thrombotic events. Overall, patients have commensurate changes in both pro- and antihemostatic pathways. This new hemostatic balance, however, appears much more fragile than the hemostatic balance in individuals with normal liver function, and patients with liver disease can readily experience both hemostasis-related bleeding and thrombotic events. These insights into the hemostatic balance in patients with liver disease have led to revised recommendations for clinical management of hemostasis. In 2020, an SSC working group within the ISTH has been founded with the aim to disseminate new concepts on prevention and treatment of bleeding and thrombosis in patients with liver disease. The current document will outline the hemostatic changes in patients with liver disease, the limitations of routine diagnostic tests of hemostasis, and the concept of rebalanced hemostasis.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Lisman T, Hernandez-Gea V, Magnusson M, et al. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease. J Thromb Haemost. 2021. PMID: 33792172. doi:10.1111/jth.15239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。